Hear from ACD at the Biomarkers & Immuno-Oncology World Congress 

Learn how the RNAscope™ Assay is expanding CDx strategies.

RNAscope is a clinically validated in situ hybridization assay that enables multiplexed tissue expression analysis in routine clinical biopsy tissues. RNAscope is considered one of the most sensitive and specific platforms for tissue-based expression analysis. It is enabling faster, robust and wide dynamic range tissue-based biomarker expression analysis for accurate correlation to treatment outcome and selection of responsive patient for clinical trial enrollment and CDx.